Evidence map›Paper›PMID 41678638›Full record

ArticleScience (New York, N.Y.)2026

Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation.

Mohamed A El-Brolosy, Atharv Oak, An T Hoang, Yassine Damergi, André Fischer, Reuben A Saunders, Jingchuan Luo, Amer Balabaki, Jeremy Guez, Troy W Whitfield and 7 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Integrating 730,947 exome sequences with clinical literature improves gene discovery.medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mohamed A El-BrolosyHarvard Society of Fellows, Cambridge, MA, USA.ORCID 0000-0003-2433-1851
Atharv Oak *Whitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0003-1441-520X
An T Hoang *Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Yassine Damergi *Whitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0009-0002-0336-8524
André Fischer *Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
Reuben A SaundersHarvard Society of Fellows, Cambridge, MA, USA.
Jingchuan LuoWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0002-6450-7172
Amer BalabakiWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0002-1509-886X
Jeremy GuezProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0009-0007-6406-5187
Troy W WhitfieldWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0002-2026-4201
Seth R GoldmanNascent Transcriptomics Core, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-5096-3778
Arash LatifkarWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0001-8682-1077
Yuancheng Ryan LuWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0002-5982-3963
Didier Y R StainierMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0002-0382-0026
Konrad J KarczewskiProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-2878-4671
Olivia CorradinWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0002-9484-0873
Jonathan S WeissmanWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0003-2445-670X

Funding

Exploring Transcriptional Adaptation: Therapeutic Potential and Impact on Human GeneticsK99HG014205 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Mohamed El-Brolosy · 2025 to 2026
$357k
Howard Hughes Medical InstituteNHGRI NIH HHS K99 HG014205
6 · The paper itself

Abstract

Transcriptional adaptation (TA) is a genetic robustness mechanism through which mutant messenger RNA (mRNA) decay induces sequence-dependent up-regulation of so-called adapting genes. How cytoplasmically generated mRNA fragments affect nuclear transcription remains poorly understood. Using genome-wide CRISPR screens, we uncover ILF3 as an RNA binding protein connecting cytoplasmic mRNA decay and transcription during TA and show that it is required for a range of TA substrates. ILF3 is enriched at adapting genes' RNAs, and its artificial recruitment through dCas13 promotes gene expression. Using tiling oligonucleotide screens, we identify trigger RNA fragments that activate adapting genes when introduced into cells. Further functional dissection reveals a critical role for homology between trigger and target sequences. These findings enhance our molecular understanding of TA and inform the design of programmable oligonucleotides for gene expression augmentation.

Indexed as

CytoplasmProtein BiosynthesisRNA-Binding ProteinsRNA, MessengerRNA StabilityTranscription, GeneticCRISPR-Cas SystemsHEK293 CellsHumansRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID41678638
PMCPMC13286266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.